TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05118763

Intranasal INNA-051 for Prevention of COVID-19 in Adults

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Sponsor decision”

The sponsor’s own words in the registry.

Life of this trial

202120222023Registered2021-10-27Planned start2022-03-01 (planned)Withdrawn (as of)2022-04-14

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
ENA Respiratory Pty Ltd
Sponsor type
Industry
Conditions
COVID-19 Pandemic
Interventions
INNA-051; Placebo
Participants
0

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.